Listed

Biotricity Inc.

BTCYOTCCIK 1630113HealthcareFiscal year ends Mar 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$4.3m, Q1 FY2027
Operating income$158.1k, Q1 FY2027
Net income−$959.5k, Q1 FY2027
Biotricity Inc., income statement, quarterly
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31Q4 FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q4 FY20262026-03-31Q1 FY20272026-06-30
Revenue$k2,891Revenue, Q2 FY2024, three months to 2023-09-30$2.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure2,973Revenue, Q3 FY2024, three months to 2023-12-31$3.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure3,178Revenue, Q4 FY2024, three months to 2024-03-31$3.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K/A filed 2025-07-18, accession 0001641172-25-020105. Derived: 12-month figure less the 9-month figure.Report this figure3,202Revenue, Q1 FY2025, three months to 2024-06-30$3.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figure3,267Revenue, Q2 FY2025, three months to 2024-09-30$3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure3,619Revenue, Q3 FY2025, three months to 2024-12-31$3.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure3,703Revenue, Q4 FY2025, three months to 2025-03-31$3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure3,874Revenue, Q1 FY2026, three months to 2025-06-30$3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure3,886Revenue, Q2 FY2026, three months to 2025-09-30$3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure3,988Revenue, Q3 FY2026, three months to 2025-12-31$4.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure4,251Revenue, Q4 FY2026, three months to 2026-03-31$4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure4,277Revenue, Q1 FY2027, three months to 2026-06-30$4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Cost of revenue$k892Cost of revenue, Q2 FY2024, three months to 2023-09-30$892.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure805Cost of revenue, Q3 FY2024, three months to 2023-12-31$805.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure906Cost of revenue, Q4 FY2024, three months to 2024-03-31$906.0k. XBRL concept us-gaap:CostOfRevenue. 10-K/A filed 2025-07-18, accession 0001641172-25-020105. Derived: 12-month figure less the 9-month figure.Report this figure839Cost of revenue, Q1 FY2025, three months to 2024-06-30$838.6k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figure808Cost of revenue, Q2 FY2025, three months to 2024-09-30$807.7k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure855Cost of revenue, Q3 FY2025, three months to 2024-12-31$855.1k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure724Cost of revenue, Q4 FY2025, three months to 2025-03-31$724.4k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure757Cost of revenue, Q1 FY2026, three months to 2025-06-30$757.2k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure704Cost of revenue, Q2 FY2026, three months to 2025-09-30$704.3k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure736Cost of revenue, Q3 FY2026, three months to 2025-12-31$736.3k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure852Cost of revenue, Q4 FY2026, three months to 2026-03-31$851.6k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure746Cost of revenue, Q1 FY2027, three months to 2026-06-30$746.1k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Gross profit$k1,999Gross profit, Q2 FY2024, three months to 2023-09-30$2.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure2,168Gross profit, Q3 FY2024, three months to 2023-12-31$2.2m. XBRL concept us-gaap:GrossProfit. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure2,272Gross profit, Q4 FY2024, three months to 2024-03-31$2.3m. XBRL concept us-gaap:GrossProfit. 10-K/A filed 2025-07-18, accession 0001641172-25-020105. Derived: 12-month figure less the 9-month figure.Report this figure2,363Gross profit, Q1 FY2025, three months to 2024-06-30$2.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figure2,459Gross profit, Q2 FY2025, three months to 2024-09-30$2.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure2,764Gross profit, Q3 FY2025, three months to 2024-12-31$2.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure2,978Gross profit, Q4 FY2025, three months to 2025-03-31$3.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure3,117Gross profit, Q1 FY2026, three months to 2025-06-30$3.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure3,181Gross profit, Q2 FY2026, three months to 2025-09-30$3.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure3,251Gross profit, Q3 FY2026, three months to 2025-12-31$3.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure3,399Gross profit, Q4 FY2026, three months to 2026-03-31$3.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure3,531Gross profit, Q1 FY2027, three months to 2026-06-30$3.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Research and development$k698Research and development, Q2 FY2024, three months to 2023-09-30$697.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure453Research and development, Q3 FY2024, three months to 2023-12-31$453.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure708Research and development, Q4 FY2024, three months to 2024-03-31$708.3k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K/A filed 2025-07-18, accession 0001641172-25-020105. Derived: 12-month figure less the 9-month figure.Report this figure514Research and development, Q1 FY2025, three months to 2024-06-30$513.9k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figure518Research and development, Q2 FY2025, three months to 2024-09-30$518.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure551Research and development, Q3 FY2025, three months to 2024-12-31$551.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure573Research and development, Q4 FY2025, three months to 2025-03-31$572.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure696Research and development, Q1 FY2026, three months to 2025-06-30$696.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure603Research and development, Q2 FY2026, three months to 2025-09-30$602.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure624Research and development, Q3 FY2026, three months to 2025-12-31$623.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure842Research and development, Q4 FY2026, three months to 2026-03-31$841.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure673Research and development, Q1 FY2027, three months to 2026-06-30$673.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Selling, general and administrative$k3,487Selling, general and administrative, Q2 FY2024, three months to 2023-09-30$3.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure2,997Selling, general and administrative, Q3 FY2024, three months to 2023-12-31$3.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure4,608Selling, general and administrative, Q4 FY2024, three months to 2024-03-31$4.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K/A filed 2025-07-18, accession 0001641172-25-020105. Derived: 12-month figure less the 9-month figure.Report this figure2,966Selling, general and administrative, Q1 FY2025, three months to 2024-06-30$3.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figure2,249Selling, general and administrative, Q2 FY2025, three months to 2024-09-30$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure2,382Selling, general and administrative, Q3 FY2025, three months to 2024-12-31$2.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure3,261Selling, general and administrative, Q4 FY2025, three months to 2025-03-31$3.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure2,139Selling, general and administrative, Q1 FY2026, three months to 2025-06-30$2.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure2,305Selling, general and administrative, Q2 FY2026, three months to 2025-09-30$2.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure2,187Selling, general and administrative, Q3 FY2026, three months to 2025-12-31$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure1,863Selling, general and administrative, Q4 FY2026, three months to 2026-03-31$1.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure2,699Selling, general and administrative, Q1 FY2027, three months to 2026-06-30$2.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Operating income$k(2,186)Operating income, Q2 FY2024, three months to 2023-09-30−$2.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure(1,282)Operating income, Q3 FY2024, three months to 2023-12-31−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure(3,044)Operating income, Q4 FY2024, three months to 2024-03-31−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2025-07-18, accession 0001641172-25-020105. Derived: 12-month figure less the 9-month figure.Report this figure(1,117)Operating income, Q1 FY2025, three months to 2024-06-30−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figure(308)Operating income, Q2 FY2025, three months to 2024-09-30−$307.7k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure(169)Operating income, Q3 FY2025, three months to 2024-12-31−$169.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure(855)Operating income, Q4 FY2025, three months to 2025-03-31−$855.5k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure282Operating income, Q1 FY2026, three months to 2025-06-30$281.9k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure274Operating income, Q2 FY2026, three months to 2025-09-30$273.8k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure441Operating income, Q3 FY2026, three months to 2025-12-31$440.9k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure695Operating income, Q4 FY2026, three months to 2026-03-31$694.6k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure158Operating income, Q1 FY2027, three months to 2026-06-30$158.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Interest expense$k753Interest expense, Q2 FY2024, three months to 2023-09-30$753.3k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure790Interest expense, Q3 FY2024, three months to 2023-12-31$790.1k. XBRL concept us-gaap:InterestExpense. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure815Interest expense, Q4 FY2024, three months to 2024-03-31$814.9k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-06-27, accession 0001493152-24-025344. Derived: 12-month figure less the 9-month figure.Report this figure769Interest expense, Q1 FY2025, three months to 2024-06-30$768.7k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-19, accession 0001493152-24-033159.Report this figure752Interest expense, Q2 FY2025, three months to 2024-09-30$752.1k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure850Interest expense, Q3 FY2025, three months to 2024-12-31$849.5k. XBRL concept us-gaap:InterestExpense. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure892Interest expense, Q4 FY2025, three months to 2025-03-31$891.8k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure850Interest expense, Q1 FY2026, three months to 2025-06-30$850.3k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure860Interest expense, Q2 FY2026, three months to 2025-09-30$860.4k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure810Interest expense, Q3 FY2026, three months to 2025-12-31$810.3k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure841Interest expense, Q4 FY2026, three months to 2026-03-31$840.9k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure852Interest expense, Q1 FY2027, three months to 2026-06-30$851.8k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Net income$k(3,691)Net income, Q2 FY2024, three months to 2023-09-30−$3.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure(2,808)Net income, Q3 FY2024, three months to 2023-12-31−$2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure(4,182)Net income, Q4 FY2024, three months to 2024-03-31−$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2025-07-18, accession 0001641172-25-020105. Derived: 12-month figure less the 9-month figure.Report this figure(3,695)Net income, Q1 FY2025, three months to 2024-06-30−$3.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figure(1,562)Net income, Q2 FY2025, three months to 2024-09-30−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure(1,229)Net income, Q3 FY2025, three months to 2024-12-31−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure(1,936)Net income, Q4 FY2025, three months to 2025-03-31−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure(672)Net income, Q1 FY2026, three months to 2025-06-30−$672.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure(691)Net income, Q2 FY2026, three months to 2025-09-30−$690.9k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure(717)Net income, Q3 FY2026, three months to 2025-12-31−$717.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure(324)Net income, Q4 FY2026, three months to 2026-03-31−$324.2k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure(959)Net income, Q1 FY2027, three months to 2026-06-30−$959.5k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Diluted EPS$ per share(0.44)Diluted EPS, Q2 FY2024, three months to 2023-09-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure(0.34)Diluted EPS, Q3 FY2024, three months to 2023-12-31−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figurenot reported(0.49)Diluted EPS, Q1 FY2025, three months to 2024-06-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figure(0.07)Diluted EPS, Q2 FY2025, three months to 2024-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure(0.05)Diluted EPS, Q3 FY2025, three months to 2024-12-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figurenot reported(0.03)Diluted EPS, Q1 FY2026, three months to 2025-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure(0.03)Diluted EPS, Q2 FY2026, three months to 2025-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure(0.04)Diluted EPS, Q3 FY2026, three months to 2025-12-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figurenot reported(0.05)Diluted EPS, Q1 FY2027, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Basic EPS$ per share(0.44)Basic EPS, Q2 FY2024, three months to 2023-09-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure(0.34)Basic EPS, Q3 FY2024, three months to 2023-12-31−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figurenot reported(0.49)Basic EPS, Q1 FY2025, three months to 2024-06-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figure(0.07)Basic EPS, Q2 FY2025, three months to 2024-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure(0.05)Basic EPS, Q3 FY2025, three months to 2024-12-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figurenot reported(0.03)Basic EPS, Q1 FY2026, three months to 2025-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure(0.03)Basic EPS, Q2 FY2026, three months to 2025-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure(0.04)Basic EPS, Q3 FY2026, three months to 2025-12-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figurenot reported(0.05)Basic EPS, Q1 FY2027, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure

Balance sheet

Cash and equivalents$466.5k, Q1 FY2027
Shareholders' equity−$35.4m, Q1 FY2027
Biotricity Inc., balance sheet, quarterly
Line itemUnitQ3 FY20242023-12-31FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31FY20252025-03-31Q1 FY20262025-06-30period not labelled2025-08-31Q2 FY20262025-09-30Q3 FY20262025-12-31FY20262026-03-31Q1 FY20272026-06-30
Cash and equivalents$m0.1Cash and equivalents, Q3 FY2024, at 2023-12-31$85.1k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-20, accession 0001493152-24-007244.Report this figure0.8Cash and equivalents, FY2024, at 2024-03-31$786.1k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K/A filed 2025-07-18, accession 0001641172-25-020105.Report this figure0.1Cash and equivalents, Q1 FY2025, at 2024-06-30$100.7k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-19, accession 0001493152-24-033159.Report this figure0.2Cash and equivalents, Q2 FY2025, at 2024-09-30$173.3k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure0.5Cash and equivalents, Q3 FY2025, at 2024-12-31$509.6k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure0.4Cash and equivalents, FY2025, at 2025-03-31$365.1k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure0.4Cash and equivalents, Q1 FY2026, at 2025-06-30$391.3k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figurenot reported0.3Cash and equivalents, Q2 FY2026, at 2025-09-30$308.5k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure0.3Cash and equivalents, Q3 FY2026, at 2025-12-31$256.4k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure0.1Cash and equivalents, FY2026, at 2026-03-31$149.8k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure0.5Cash and equivalents, Q1 FY2027, at 2026-06-30$466.5k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Current assets$m3.9Current assets, Q3 FY2024, at 2023-12-31$3.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-20, accession 0001493152-24-007244.Report this figure4.5Current assets, FY2024, at 2024-03-31$4.5m. XBRL concept us-gaap:AssetsCurrent. 10-K/A filed 2025-07-18, accession 0001641172-25-020105.Report this figure4.1Current assets, Q1 FY2025, at 2024-06-30$4.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-19, accession 0001493152-24-033159.Report this figure4.1Current assets, Q2 FY2025, at 2024-09-30$4.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure4.9Current assets, Q3 FY2025, at 2024-12-31$4.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure4.6Current assets, FY2025, at 2025-03-31$4.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure5.1Current assets, Q1 FY2026, at 2025-06-30$5.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figurenot reported5.5Current assets, Q2 FY2026, at 2025-09-30$5.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure5.0Current assets, Q3 FY2026, at 2025-12-31$5.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure5.9Current assets, FY2026, at 2026-03-31$5.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure5.6Current assets, Q1 FY2027, at 2026-06-30$5.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Total assets$m5.5Total assets, Q3 FY2024, at 2023-12-31$5.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-20, accession 0001493152-24-007244.Report this figure5.9Total assets, FY2024, at 2024-03-31$5.9m. XBRL concept us-gaap:Assets. 10-K/A filed 2025-07-18, accession 0001641172-25-020105.Report this figure5.4Total assets, Q1 FY2025, at 2024-06-30$5.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-19, accession 0001493152-24-033159.Report this figure5.3Total assets, Q2 FY2025, at 2024-09-30$5.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure6.0Total assets, Q3 FY2025, at 2024-12-31$6.0m. XBRL concept us-gaap:Assets. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure5.6Total assets, FY2025, at 2025-03-31$5.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure6.0Total assets, Q1 FY2026, at 2025-06-30$6.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figurenot reported6.3Total assets, Q2 FY2026, at 2025-09-30$6.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure5.7Total assets, Q3 FY2026, at 2025-12-31$5.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure6.4Total assets, FY2026, at 2026-03-31$6.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure6.0Total assets, Q1 FY2027, at 2026-06-30$6.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Current liabilities$m18.6Current liabilities, Q3 FY2024, at 2023-12-31$18.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-20, accession 0001493152-24-007244.Report this figure22.7Current liabilities, FY2024, at 2024-03-31$22.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K/A filed 2025-07-18, accession 0001641172-25-020105.Report this figure20.6Current liabilities, Q1 FY2025, at 2024-06-30$20.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-19, accession 0001493152-24-033159.Report this figure21.5Current liabilities, Q2 FY2025, at 2024-09-30$21.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure21.1Current liabilities, Q3 FY2025, at 2024-12-31$21.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure20.6Current liabilities, FY2025, at 2025-03-31$20.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure21.8Current liabilities, Q1 FY2026, at 2025-06-30$21.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figurenot reported23.6Current liabilities, Q2 FY2026, at 2025-09-30$23.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure23.8Current liabilities, Q3 FY2026, at 2025-12-31$23.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure37.1Current liabilities, FY2026, at 2026-03-31$37.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure37.3Current liabilities, Q1 FY2027, at 2026-06-30$37.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Total liabilities$m32.2Total liabilities, Q3 FY2024, at 2023-12-31$32.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-20, accession 0001493152-24-007244.Report this figure35.9Total liabilities, FY2024, at 2024-03-31$35.9m. XBRL concept us-gaap:Liabilities. 10-K/A filed 2025-07-18, accession 0001641172-25-020105.Report this figure33.0Total liabilities, Q1 FY2025, at 2024-06-30$33.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-19, accession 0001493152-24-033159.Report this figure34.2Total liabilities, Q2 FY2025, at 2024-09-30$34.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure35.8Total liabilities, Q3 FY2025, at 2024-12-31$35.8m. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure35.7Total liabilities, FY2025, at 2025-03-31$35.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure36.8Total liabilities, Q1 FY2026, at 2025-06-30$36.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figurenot reported38.0Total liabilities, Q2 FY2026, at 2025-09-30$38.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure38.2Total liabilities, Q3 FY2026, at 2025-12-31$38.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure39.4Total liabilities, FY2026, at 2026-03-31$39.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure39.7Total liabilities, Q1 FY2027, at 2026-06-30$39.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Short-term borrowings$mnot reportednot reportednot reportednot reportednot reportednot reportednot reported1.2Short-term borrowings, period not labelled, at 2025-08-31$1.1m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figurenot reportednot reportednot reportednot reported
Shareholders' equity$m(27.8)Shareholders' equity, Q3 FY2024, at 2023-12-31−$27.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure(31.5)Shareholders' equity, FY2024, at 2024-03-31−$31.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure(29.8)Shareholders' equity, Q1 FY2025, at 2024-06-30−$29.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure(31.2)Shareholders' equity, Q2 FY2025, at 2024-09-30−$31.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure(31.9)Shareholders' equity, Q3 FY2025, at 2024-12-31−$31.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure(32.0)Shareholders' equity, FY2025, at 2025-03-31−$32.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure(32.8)Shareholders' equity, Q1 FY2026, at 2025-06-30−$32.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figurenot reported(33.4)Shareholders' equity, Q2 FY2026, at 2025-09-30−$33.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure(34.2)Shareholders' equity, Q3 FY2026, at 2025-12-31−$34.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure(34.7)Shareholders' equity, FY2026, at 2026-03-31−$34.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure(35.4)Shareholders' equity, Q1 FY2027, at 2026-06-30−$35.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure

Cash flow

Operating cash flow$507.2k, Q1 FY2027
Biotricity Inc., cash flow, quarterly
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31Q4 FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q4 FY20262026-03-31Q1 FY20272026-06-30
Operating cash flow$k(2,390)Operating cash flow, Q2 FY2024, three months to 2023-09-30−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001493152-24-046028. Derived: 6-month figure less the 3-month figure.Report this figure(1,306)Operating cash flow, Q3 FY2024, three months to 2023-12-31−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664. Derived: 9-month figure less the 6-month figure.Report this figure(1,166)Operating cash flow, Q4 FY2024, three months to 2024-03-31−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2025-07-18, accession 0001641172-25-020105. Derived: 12-month figure less the 9-month figure.Report this figure(1,494)Operating cash flow, Q1 FY2025, three months to 2024-06-30−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figure(397)Operating cash flow, Q2 FY2025, three months to 2024-09-30−$397.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001493152-25-023361. Derived: 6-month figure less the 3-month figure.Report this figure(88.1)Operating cash flow, Q3 FY2025, three months to 2024-12-31−$88.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-11, accession 0001493152-26-006211. Derived: 9-month figure less the 6-month figure.Report this figure(401)Operating cash flow, Q4 FY2025, three months to 2025-03-31−$400.8k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure(373)Operating cash flow, Q1 FY2026, three months to 2025-06-30−$373.4k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure416Operating cash flow, Q2 FY2026, three months to 2025-09-30$415.6k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001493152-25-023361. Derived: 6-month figure less the 3-month figure.Report this figure(740)Operating cash flow, Q3 FY2026, three months to 2025-12-31−$740.3k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-11, accession 0001493152-26-006211. Derived: 9-month figure less the 6-month figure.Report this figure(20.9)Operating cash flow, Q4 FY2026, three months to 2026-03-31−$20.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure507Operating cash flow, Q1 FY2027, three months to 2026-06-30$507.2k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Capital expenditure$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Dividends paid$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)23.10m, Q1 FY2027
Biotricity Inc., shares, quarterly
Line itemUnitQ2 FY20232022-09-30Q3 FY20232022-12-31Q1 FY20242023-06-30Q2 FY20242023-09-30Q3 FY20242023-12-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q1 FY20272026-06-30
Diluted shares (weighted)m shares8.6Diluted shares (weighted), Q2 FY2023, three months to 2022-09-308,642,937 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001493152-23-041243.Report this figure8.7Diluted shares (weighted), Q3 FY2023, three months to 2022-12-318,690,506 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-20, accession 0001493152-24-007244.Report this figure8.8Diluted shares (weighted), Q1 FY2024, three months to 2023-06-308,752,510 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-19, accession 0001493152-24-033159.Report this figure8.8Diluted shares (weighted), Q2 FY2024, three months to 2023-09-308,795,742 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001493152-24-046028.Report this figure9.0Diluted shares (weighted), Q3 FY2024, three months to 2023-12-318,979,430 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2025-02-20, accession 0001493152-25-007664.Report this figure14.2Diluted shares (weighted), Q1 FY2025, three months to 2024-06-3014,169,441 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001641172-25-023709.Report this figure22.5Diluted shares (weighted), Q2 FY2025, three months to 2024-09-3022,493,626 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure24.2Diluted shares (weighted), Q3 FY2025, three months to 2024-12-3124,232,369 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure26.3Diluted shares (weighted), Q1 FY2026, three months to 2025-06-3026,284,734 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure26.8Diluted shares (weighted), Q2 FY2026, three months to 2025-09-3026,767,370 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure27.6Diluted shares (weighted), Q3 FY2026, three months to 2025-12-3127,590,766 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure23.1Diluted shares (weighted), Q1 FY2027, three months to 2026-06-3023,096,373 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure

Shares outstanding: 19.91mShares outstanding, period not labelled, at 2026-08-1919,914,003 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure at Aug 19, 2026, from the cover of the 10-Q filed Aug 19, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.